The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis
Open Access
- 19 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Nutrition
- Vol. 75 (11), 1540-1554
- https://doi.org/10.1038/s41430-021-00875-9
Abstract
To determine the effect of oat β‑glucan (OBG) on acute glucose and insulin responses and identify significant effect modifiers we searched the MEDLINE, EMBASE, and Cochrane databases through October 27, 2020 for acute, crossover, controlled feeding trials investigating the effect of adding OBG (concentrate or oat-bran) to carbohydrate-containing test-meals compared to comparable or different carbohydrate-matched control-meals in humans regardless of health status. The primary outcome was glucose incremental area-under-the-curve (iAUC). Secondary outcomes were insulin iAUC, and glucose and insulin incremental peak-rise (iPeak). Two reviewers extracted the data and assessed risk-of-bias and certainty-of-evidence (GRADE). Data were pooled using generic inverse-variance with random-effects model and expressed as ratio-of-means with [95% CIs]. We included 103 trial comparisons (N = 538). OBG reduced glucose iAUC and iPeak by 23% (0.77 [0.74, 0.81]) and 28% (0.72 [0.64, 0.76]) and insulin by 22% (0.78 [0.72, 0.85]) and 24% (0.76 [0.65, 0.88]), respectively. Dose, molecular-weight, and comparator were significant effect modifiers of glucose iAUC and iPeak. Significant linear dose-response relationships were observed for all outcomes. OBG molecular-weight >300 kg/mol significantly reduced glucose iAUC and iPeak, whereas molecular-weight p = 0.03) and iPeak (39 vs 25%, p < 0.01) were significantly larger with different vs comparable control-meals. Outcomes were similar in participants with and without diabetes. All outcomes had high certainty-of-evidence. In conclusion, current evidence indicates that adding OBG to carbohydrate-containing meals reduces glycaemic and insulinaemic responses. However, the magnitude of glucose reduction depends on OBG dose, molecular-weight, and the comparator.Keywords
This publication has 97 references indexed in Scilit:
- Attenuation of glycemic responses by oat β-glucan solutions and viscoelastic gels is dependent on molecular weight distributionFood & Function, 2012
- Meta-Analysis for Linear and Nonlinear Dose-Response Relations: Examples, an Evaluation of Approximations, and SoftwareAmerican Journal of Epidemiology, 2011
- An oat bran meal influences blood insulin levels and related gene sets in peripheral blood mononuclear cells of healthy subjectsGenes & Nutrition, 2011
- Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or treated with immunomodulatory agentsMediterranean Journal of Hematology and Infectious Diseases, 2010
- Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 DiabetesJAMA, 2008
- The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation studyBMC Medical Research Methodology, 2008
- Measuring glycaemic responses: duplicate fasting samples or duplicate measures of one fasting sample?British Journal of Nutrition, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986